# This common gout drug may slash heart attack and stroke risk - Date: 2026-04-15 - Category: Biotech & Life Sciences The study found a striking dose-response: patients hitting serum urate below 5 mg/dL got a 23% risk reduction (HR 0.77), while those at the standard guideline target of 6 mg/dL got only 9% (HR 0.91). Only 27% of patients in the study reached target at all. ---